Thursday, February 19, 2015

Lilly Extends Cholesterol Therapy Study

Eli Lilly said it would extend a Phase 3 trial of its investigational treatment for high-risk cases of atherosclerotic cardiovascular disease.



from WSJ.com: US Business http://ift.tt/1G7WVl8

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)